Navigation Links
Shire plc: Results of the Annual General Meeting Held on April 28, 2009
Date:4/28/2009

DUBLIN, April 28 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announces that at its Annual General Meeting today, all resolutions contained in the notice of meeting were duly passed and the results of the poll are as follows:

                                        For*      Against  Withheld**
    1.     To receive the
           Company's accounts
           together with the
           director's and
           auditor's reports    385,589,148    2,271,000     26,380
    2.     To approve the
           Remuneration Report  307,647,526   60,796,610 19,442,392
    3.     To elect Dr Barry
           Price as a Director
           of the Company       356,441,471   31,425,618     19,439
    4.     To re-appoint
           Deloitte LLP as
           Auditors of the
           Company              387,555,848      311,630     19,050
    5.     To authorize the
           Audit, Compliance
           and Risk Committee
           to determine the
           remuneration of the
           Auditors             387,180,598      671,746     34,184
    6.     To authorize the
           allotment of shares  332,997,412   54,868,377     20,739
    7.     To authorize the
           disapplication of
           pre-emption rights   387,558,665      297,124     30,739
    8.     To authorize market
           purchases            387,693,316      173,212     20,000

    * These figures include discretionary votes

** A vote "withheld" is not a vote in law and is not counted in the calculation of the votes "for" or "against" a resolution.

Two copies of all resolutions passed, other than resolutions concerning ordinary business, will shortly be submitted to the UK Listing Authority and will be available for inspection at the UK Li
'/>"/>

SOURCE Shire Plc
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Shire plc: First Quarter 2009 Results Date Notification - April 30, 2009
2. Shire Files Lawsuit Against Natco Pharma for Infringement of FOSRENOL(R) (lanthanum carbonate) Patents
3. Shire and GlaxoSmithKline Enter Agreement to Co-promote VYVANSE(R) (lisdexamfetamine dimesylate) CII for the Treatment of Adults With ADHD
4. Publication of Shire plcs Annual Report 2008
5. Shires Project Playground Gives Boost to Philadelphia
6. Shire Files Lawsuit Against Mylan for Infringement of FOSRENOL(R) (Lanthanum Carbonate) Patent
7. Shire Files Lawsuit Against Barr Laboratories for Infringement of FOSRENOL(R) (Lanthanum Carbonate) Patents
8. Shire Announces Opening of Office in Japan
9. Shire to Enter European ADHD Market With the Acquisition of EQUASYM(R) IR and XL
10. Shire Delivers Excellent Growth for the Year, With the new Product Portfolio Achieving Sales of $1 Billion
11. Shire Receives FOSRENOL Paragraph IV Notice Letters from Barr Laboratories and Mylan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/17/2013)... Z Trim Holdings, Inc. (OTC Markets: ... ingredients to a variety of industries, today announced ... application at this year,s annual Institute of Food ... , July 13-16. The Company will demonstrate how ... in meat products thereby helping manufacturers lower costs ...
(Date:6/17/2013)... , June 17, 2013 ... ) has announced the addition of the ... - by Formulations [Liposomes, Microspheres, & Nanoparticles], ... Pen, Needle Free & Auto Injectors] & ... their offering. ,      (Logo: ...
(Date:6/17/2013)... As interest increases in developing novel biomarker ... the need to keep up with the pace of ... the first in a series titled “Better Methods for ... a range of technologies, introduces a novel method for ... proteins than either ELISA or traditional LCMS can achieve. ...
(Date:6/17/2013)... VARTA Microbattery, the ... the opening of its new North American Headquarters ... business community received an inside look at the ... powered the camera Neil Armstrong used to capture ... showcasing VARTA’s many historic achievements and innovative new ...
Breaking Biology Technology:Z Trim to Spotlight New Meat Applications at IFT 2013 in Chicago 2Z Trim to Spotlight New Meat Applications at IFT 2013 in Chicago 3North America Injectable Drug Delivery Market - by Formulations, Devices & Therapeutics- Forecasts to 2017 2North America Injectable Drug Delivery Market - by Formulations, Devices & Therapeutics- Forecasts to 2017 3Quantitative Analysis of Biomarkers, New Life Science Webinar Hosted by Xtalks 2VARTA Microbattery Celebrates New North American Headquarters in Rye, NY 2VARTA Microbattery Celebrates New North American Headquarters in Rye, NY 3VARTA Microbattery Celebrates New North American Headquarters in Rye, NY 4
... and existing investors complete a $17.3 million Series C investment ... Rosenthal, appointed as CEO , , - Aggressive launch ... , , - Expansion of management team, R&D and ... and GALWAY, Ireland, June 15 Cappella, Inc. ...
... 2009 (EurekAlert)--Advanced Cell Technology, Inc. (OTC:ACTC.PK) and its ... and efficacy of human embryonic stem cell (hESC)-derived ... suitable for human clinical trials. Two important early ... for the treatment of age-related macular degeneration and ...
... MedPredict Market Research, a global provider of pharmaceutical ... report entitled "Thought Leader Insight & Analysis: Alzheimer,s Disease," ... biotech companies with a stake in the market for ... http://www.medpredict.com/website/home.aspx ). , , ...
Cached Biology Technology:Cappella Inc. Secures $17.3 Million Series C Investment 2Cappella Inc. Secures $17.3 Million Series C Investment 3Cappella Inc. Secures $17.3 Million Series C Investment 4Cappella Inc. Secures $17.3 Million Series C Investment 5Assessment of safety and efficacy of human embryonic stem cell therapy 2Assessment of safety and efficacy of human embryonic stem cell therapy 3New MedPredict Report Reveals Top Alzheimer's Experts' Insights on Diagnostics and Treatments in Development Pipeline 2
(Date:6/17/2013)... TORONTO, June 17, 2013How kids eat their food may turn ... according to a new study out of St. Michael,s Hospital. ... family physician, found a significant association between poor eating ... of non-HDL or "bad" cholesterol, putting them at ... appeared online in the Canadian Medical Association Journal ...
(Date:6/17/2013)... Vitamin D supplementation may help delay early onset of ... results were presented Monday at The Endocrine Society,s 95th ... generally begins between the ages of 10 and 14. ... 16 years of age. Precocious puberty is diagnosed in ... 8; in boys, it is diagnosed when these changes ...
(Date:6/17/2013)... Amphibian populations are declining worldwide and a major ... by bullfrogs, but a two-year study shows they can ... bullfrogs are a tolerant carrier host that just spreads ... eggs in controlled experimental conditions, they found at least ... also called Bd or a chytrid fungus, can be ...
Breaking Biology News(10 mins):Poor eating behaviors may put preschoolers at risk for later health problems 2Vitamin D supplementation may delay precocious puberty in girls 2Bullfrogs may help spread deadly amphibian fungus, but also die from it 2
... 2010, NEW ORLEANS, LA Broncus Technologies, Inc., a ... for lung diseases, announced today at the American ... its LungPoint system version 2.1. The bronchoscopic navigation ... the meeting. These highlight the clinical benefits of ...
... WHAT: The World Science Festival launches its first full day ... event will feature a keynote address by Harold Varmus, co-chair ... as well as a live simulcast of the announcement of ... from Oslo, Norway. A panel discussion follows, moderated by ...
... CITY (May 14, 2010)--The New York Stem Cell Foundation ... the Robertson Foundation, established by Julian and Josie Robertson. ... support, will provide funding for NYSCF-Robertson Investigators in NYSCF,s ... of the NYSCF-Robertson Stem Cell Prize. This ...
Cached Biology News:LungPoint system results presented at American Thoracic Society 2010 International Conference 2LungPoint system results presented at American Thoracic Society 2010 International Conference 3
IgD Chain C (AMS 9.1)...
Bethyl Laboratories packages antibodies, conjugates and calibrators to provide quantitative ELISA kits. Each kit contains the following components, sufficient for 1000 single well assays....
Applications: Epitope mapping, Mapping protein-protein contacts, Identification of enzyme substrates/inhibitors, Identification of receptor agonists/antagonists...
Bethyl Laboratories packages antibodies, conjugates and calibrators to provide quantitative ELISA kits. Each kit contains the following components, sufficient for 1000 single well assays....
Biology Products: